Pavmed Inc Stock Performance
PAVM Stock | USD 0.75 0.02 2.60% |
On a scale of 0 to 100, PAVmed holds a performance score of 6. The firm holds a Beta of 1.82, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, PAVmed will likely underperform. Please check PAVmed's downside variance, as well as the relationship between the accumulation distribution and price action indicator , to make a quick decision on whether PAVmed's historical price patterns will revert.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in PAVmed Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, PAVmed displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:15 | Last Split Date 2023-12-07 |
1 | Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule | 12/23/2024 |
2 | Disposition of 12450 shares by Aklog Lishan of PAVmed at 1.6 subject to Rule 16b-3 | 01/02/2025 |
3 | Lucid Diagnostics Achieves Record-Breaking Quarter with 84 percent Surge in EsoGuard DNA Test Volume - StockTitan | 01/13/2025 |
4 | Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science Diagnostic Tools Conference | 02/06/2025 |
5 | PAVmed and Subsidiary Veris Health Complete Private Placement Financing | 02/24/2025 |
6 | Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025 | 03/10/2025 |
7 | Acquisition by Deguzman Brian J. of 50000 shares of PAVmed at 1.59 subject to Rule 16b-3 | 03/11/2025 |
8 | Insider Trading | 03/14/2025 |
Begin Period Cash Flow | 39.7 M |
PAVmed |
PAVmed Relative Risk vs. Return Landscape
If you would invest 61.00 in PAVmed Inc on December 19, 2024 and sell it today you would earn a total of 14.00 from holding PAVmed Inc or generate 22.95% return on investment over 90 days. PAVmed Inc is currently generating 0.494% in daily expected returns and assumes 5.6452% risk (volatility on return distribution) over the 90 days horizon. In different words, 50% of stocks are less volatile than PAVmed, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
PAVmed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PAVmed's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PAVmed Inc, and traders can use it to determine the average amount a PAVmed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0875
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | PAVM | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
5.65 actual daily | 50 50% of assets are less volatile |
Expected Return
0.49 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average PAVmed is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PAVmed by adding it to a well-diversified portfolio.
PAVmed Fundamentals Growth
PAVmed Stock prices reflect investors' perceptions of the future prospects and financial health of PAVmed, and PAVmed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PAVmed Stock performance.
Return On Equity | -13.58 | ||||
Return On Asset | -0.96 | ||||
Profit Margin | 6.03 % | ||||
Operating Margin | (11.62) % | ||||
Current Valuation | 47.85 M | ||||
Shares Outstanding | 13.64 M | ||||
Price To Earning | (6.39) X | ||||
Price To Book | 7.42 X | ||||
Price To Sales | 2.59 X | ||||
Revenue | 2.45 M | ||||
Gross Profit | (2.37 M) | ||||
EBITDA | (75.74 M) | ||||
Net Income | (64.17 M) | ||||
Cash And Equivalents | 68.47 M | ||||
Cash Per Share | 0.75 X | ||||
Total Debt | 48.73 M | ||||
Debt To Equity | 0.79 % | ||||
Current Ratio | 1.82 X | ||||
Book Value Per Share | (0.76) X | ||||
Cash Flow From Operations | (52.04 M) | ||||
Earnings Per Share | (1.14) X | ||||
Market Capitalization | 10.45 M | ||||
Total Asset | 33.12 M | ||||
Retained Earnings | (294.43 M) | ||||
Working Capital | (29.68 M) | ||||
Current Asset | 1.97 M | ||||
Current Liabilities | 842 K | ||||
About PAVmed Performance
By examining PAVmed's fundamental ratios, stakeholders can obtain critical insights into PAVmed's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that PAVmed is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 35.24 | 33.48 | |
Return On Tangible Assets | (1.82) | (1.91) | |
Return On Capital Employed | 2.94 | 2.79 | |
Return On Assets | (1.74) | (1.83) | |
Return On Equity | 1.37 | 2.44 |
Things to note about PAVmed Inc performance evaluation
Checking the ongoing alerts about PAVmed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PAVmed Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.PAVmed Inc had very high historical volatility over the last 90 days | |
PAVmed Inc has some characteristics of a very speculative penny stock | |
PAVmed Inc has high likelihood to experience some financial distress in the next 2 years | |
The company reported the previous year's revenue of 2.45 M. Net Loss for the year was (64.17 M) with loss before overhead, payroll, taxes, and interest of (2.37 M). | |
PAVmed Inc currently holds about 68.47 M in cash with (52.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75. | |
PAVmed Inc has a frail financial position based on the latest SEC disclosures | |
Roughly 29.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from MacroaxisInsider: Insider Trading |
- Analyzing PAVmed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PAVmed's stock is overvalued or undervalued compared to its peers.
- Examining PAVmed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PAVmed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PAVmed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PAVmed's stock. These opinions can provide insight into PAVmed's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.14) | Revenue Per Share | Quarterly Revenue Growth 0.259 | Return On Assets | Return On Equity |
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.